AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE

AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE

The invention relates to a novel oral liquid dosage form of Alpha- ketoglutaric acid disodium salt which serves in the treatment of cyanide poisoning. The pharmaceutical formulation is prepared in a flavored sorbitol base to improve the taste, color, stability and bioavailability of the preparation....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GOPALAN, NATARAJAN, GUJAR, NIRANJAN LAXMAN, RAO, PUTCHA VENKATA LAKSHMANA, SINGH, POONAM, BHATTACHARYA, RAHUL, YADAV, SHIV KUMAR, RAO, POOJA, SINGH, ANIL KUMAR
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GOPALAN, NATARAJAN
GUJAR, NIRANJAN LAXMAN
RAO, PUTCHA VENKATA LAKSHMANA
SINGH, POONAM
BHATTACHARYA, RAHUL
YADAV, SHIV KUMAR
RAO, POOJA
SINGH, ANIL KUMAR
description The invention relates to a novel oral liquid dosage form of Alpha- ketoglutaric acid disodium salt which serves in the treatment of cyanide poisoning. The pharmaceutical formulation is prepared in a flavored sorbitol base to improve the taste, color, stability and bioavailability of the preparation. The formulation can also be employed as an energy-rich nutritional supplement or sports medicine to bolster the citric acid cycle or to correct hyperammonemia. The present invention also relates to a process for producing Alpha-ketoglutaric acid disodium salt based pharmaceutical compositions and methods of using such kits for the treatment of cyanide poisoning.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IN3146DEL2012A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IN3146DEL2012A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IN3146DEL2012A3</originalsourceid><addsrcrecordid>eNrjZNBz9FPwD3L0UfDxDAz1dFFw8w_yDfVxDPH091NwDFZwjnT083RxVXD0C_F08Q9x5WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Z5-xoYmZi6uPkYGhkaOxsSpAgBuWibT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE</title><source>esp@cenet</source><creator>GOPALAN, NATARAJAN ; GUJAR, NIRANJAN LAXMAN ; RAO, PUTCHA VENKATA LAKSHMANA ; SINGH, POONAM ; BHATTACHARYA, RAHUL ; YADAV, SHIV KUMAR ; RAO, POOJA ; SINGH, ANIL KUMAR</creator><creatorcontrib>GOPALAN, NATARAJAN ; GUJAR, NIRANJAN LAXMAN ; RAO, PUTCHA VENKATA LAKSHMANA ; SINGH, POONAM ; BHATTACHARYA, RAHUL ; YADAV, SHIV KUMAR ; RAO, POOJA ; SINGH, ANIL KUMAR</creatorcontrib><description>The invention relates to a novel oral liquid dosage form of Alpha- ketoglutaric acid disodium salt which serves in the treatment of cyanide poisoning. The pharmaceutical formulation is prepared in a flavored sorbitol base to improve the taste, color, stability and bioavailability of the preparation. The formulation can also be employed as an energy-rich nutritional supplement or sports medicine to bolster the citric acid cycle or to correct hyperammonemia. The present invention also relates to a process for producing Alpha-ketoglutaric acid disodium salt based pharmaceutical compositions and methods of using such kits for the treatment of cyanide poisoning.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150731&amp;DB=EPODOC&amp;CC=IN&amp;NR=3146DE2012A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150731&amp;DB=EPODOC&amp;CC=IN&amp;NR=3146DE2012A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOPALAN, NATARAJAN</creatorcontrib><creatorcontrib>GUJAR, NIRANJAN LAXMAN</creatorcontrib><creatorcontrib>RAO, PUTCHA VENKATA LAKSHMANA</creatorcontrib><creatorcontrib>SINGH, POONAM</creatorcontrib><creatorcontrib>BHATTACHARYA, RAHUL</creatorcontrib><creatorcontrib>YADAV, SHIV KUMAR</creatorcontrib><creatorcontrib>RAO, POOJA</creatorcontrib><creatorcontrib>SINGH, ANIL KUMAR</creatorcontrib><title>AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE</title><description>The invention relates to a novel oral liquid dosage form of Alpha- ketoglutaric acid disodium salt which serves in the treatment of cyanide poisoning. The pharmaceutical formulation is prepared in a flavored sorbitol base to improve the taste, color, stability and bioavailability of the preparation. The formulation can also be employed as an energy-rich nutritional supplement or sports medicine to bolster the citric acid cycle or to correct hyperammonemia. The present invention also relates to a process for producing Alpha-ketoglutaric acid disodium salt based pharmaceutical compositions and methods of using such kits for the treatment of cyanide poisoning.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz9FPwD3L0UfDxDAz1dFFw8w_yDfVxDPH091NwDFZwjnT083RxVXD0C_F08Q9x5WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Z5-xoYmZi6uPkYGhkaOxsSpAgBuWibT</recordid><startdate>20150731</startdate><enddate>20150731</enddate><creator>GOPALAN, NATARAJAN</creator><creator>GUJAR, NIRANJAN LAXMAN</creator><creator>RAO, PUTCHA VENKATA LAKSHMANA</creator><creator>SINGH, POONAM</creator><creator>BHATTACHARYA, RAHUL</creator><creator>YADAV, SHIV KUMAR</creator><creator>RAO, POOJA</creator><creator>SINGH, ANIL KUMAR</creator><scope>EVB</scope></search><sort><creationdate>20150731</creationdate><title>AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE</title><author>GOPALAN, NATARAJAN ; GUJAR, NIRANJAN LAXMAN ; RAO, PUTCHA VENKATA LAKSHMANA ; SINGH, POONAM ; BHATTACHARYA, RAHUL ; YADAV, SHIV KUMAR ; RAO, POOJA ; SINGH, ANIL KUMAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IN3146DEL2012A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>GOPALAN, NATARAJAN</creatorcontrib><creatorcontrib>GUJAR, NIRANJAN LAXMAN</creatorcontrib><creatorcontrib>RAO, PUTCHA VENKATA LAKSHMANA</creatorcontrib><creatorcontrib>SINGH, POONAM</creatorcontrib><creatorcontrib>BHATTACHARYA, RAHUL</creatorcontrib><creatorcontrib>YADAV, SHIV KUMAR</creatorcontrib><creatorcontrib>RAO, POOJA</creatorcontrib><creatorcontrib>SINGH, ANIL KUMAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOPALAN, NATARAJAN</au><au>GUJAR, NIRANJAN LAXMAN</au><au>RAO, PUTCHA VENKATA LAKSHMANA</au><au>SINGH, POONAM</au><au>BHATTACHARYA, RAHUL</au><au>YADAV, SHIV KUMAR</au><au>RAO, POOJA</au><au>SINGH, ANIL KUMAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE</title><date>2015-07-31</date><risdate>2015</risdate><abstract>The invention relates to a novel oral liquid dosage form of Alpha- ketoglutaric acid disodium salt which serves in the treatment of cyanide poisoning. The pharmaceutical formulation is prepared in a flavored sorbitol base to improve the taste, color, stability and bioavailability of the preparation. The formulation can also be employed as an energy-rich nutritional supplement or sports medicine to bolster the citric acid cycle or to correct hyperammonemia. The present invention also relates to a process for producing Alpha-ketoglutaric acid disodium salt based pharmaceutical compositions and methods of using such kits for the treatment of cyanide poisoning.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_IN3146DEL2012A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
title AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T12%3A52%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOPALAN,%20NATARAJAN&rft.date=2015-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIN3146DEL2012A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true